We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTG icon
2151
Pennant Group
PNTG
$1.35B
$166K ﹤0.01%
7,172
FOUR icon
2152
Shift4
FOUR
$3.79B
$165K ﹤0.01%
2,856
-22
-0.8% -$1.4K
VERI icon
2153
Veritone
VERI
$139M
$165K ﹤0.01%
7,336
CVI icon
2154
CVR Energy
CVI
$3.58B
$165K ﹤0.01%
9,786
MGI
2155
DELISTED
MoneyGram International, Inc. New
MGI
$164K ﹤0.01%
20,780
-540
-3% -$3.71K
NGM
2156
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$164K ﹤0.01%
9,257
KOP icon
2157
Koppers
KOP
$874M
$164K ﹤0.01%
5,230
ARQT icon
2158
Arcutis Biotherapeutics
ARQT
$3.25B
$163K ﹤0.01%
7,875
UEC icon
2159
Uranium Energy
UEC
$5.54B
$163K ﹤0.01%
48,702
+4,617
+10% +$17.8K
ATRS
2160
DELISTED
Antares Pharma, Inc.
ATRS
$163K ﹤0.01%
45,536
+3,286
+8% +$11.5K
VERV
2161
DELISTED
Verve Therapeutics
VERV
$162K ﹤0.01%
4,399
RRD
2162
DELISTED
RR Donnelley & Sons Co.
RRD
$162K ﹤0.01%
14,404
+8,183
+132% +$70.9K
VMEO
2163
DELISTED
Vimeo
VMEO
$162K ﹤0.01%
9,029
-68
-0.7% -$1.66K
LSXMK
2164
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$162K ﹤0.01%
4,114
-49
-1% -$1.9K
VXRT
2165
DELISTED
Vaxart
VXRT
$162K ﹤0.01%
25,818
-877
-3% -$5.99K
VIEW
2166
DELISTED
View, Inc. Class A Common Stock
VIEW
$162K ﹤0.01%
690
+385
+126% +$110K
YORW icon
2167
York Water
YORW
$536M
$162K ﹤0.01%
3,249
-924
-22% -$44.1K
CLW icon
2168
Clearwater Paper
CLW
$354M
$161K ﹤0.01%
4,403
GPMT
2169
Granite Point Mortgage Trust
GPMT
$58.8M
$161K ﹤0.01%
13,774
-5
-0% -$64
KRON
2170
DELISTED
Kronos Bio
KRON
$161K ﹤0.01%
11,851
KZR
2171
DELISTED
Kezar Life Sciences
KZR
$161K ﹤0.01%
962
-17
-2% -$1.92K
FTDR icon
2172
Frontdoor
FTDR
$5.83B
$161K ﹤0.01%
4,386
-81
-2% -$3.08K
BMRC icon
2173
Bank of Marin Bancorp
BMRC
$462M
$161K ﹤0.01%
4,317
BBSI icon
2174
Barrett Business Services
BBSI
$800M
$161K ﹤0.01%
9,308
PAYA
2175
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$160K ﹤0.01%
25,285

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.